Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Dividends Paid - Common (2016 - 2025)

Surgery Partners' Dividends Paid - Common history spans 12 years, with the latest figure at $57.2 million for Q4 2025.

  • For Q4 2025, Dividends Paid - Common rose 18.92% year-over-year to $57.2 million; the TTM value through Dec 2025 reached $226.0 million, up 32.55%, while the annual FY2025 figure was $226.0 million, 32.55% up from the prior year.
  • Dividends Paid - Common for Q4 2025 was $57.2 million at Surgery Partners, up from $52.5 million in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $62.3 million in Q1 2025 and bottomed at $5.1 million in Q1 2021.
  • The 5-year median for Dividends Paid - Common is $40.2 million (2024), against an average of $40.9 million.
  • The largest annual shift saw Dividends Paid - Common surged 1175.0% in 2021 before it fell 10.26% in 2023.
  • A 5-year view of Dividends Paid - Common shows it stood at $5.1 million in 2021, then skyrocketed by 611.76% to $36.3 million in 2022, then fell by 3.31% to $35.1 million in 2023, then surged by 37.04% to $48.1 million in 2024, then grew by 18.92% to $57.2 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Dividends Paid - Common are $57.2 million (Q4 2025), $52.5 million (Q3 2025), and $54.0 million (Q2 2025).